Works matching IS 09509232 AND DT 2007 AND VI 26 AND IP 19

Results: 16

Transforming growth factor α promotes sequential conversion of mature astrocytes into neural progenitors and stem cells.

Published in:

Oncogene, 2007, v. 26, n. 19, p. 2695, doi. 10.1038/sj.onc.1210071

By:

Sharif, A.;
Legendre, P.;
Prévot, V.;
Allet, C.;
Romao, L.;
Studler, J.-M.;
Chneiweiss, H.;
Junier, M.-P.

Publication type:

Article

Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors.

Published in:

Oncogene, 2007, v. 26, n. 19, p. 2791, doi. 10.1038/sj.onc.1210072

By:

Beltran, A.;
Parikh, S.;
Liu, Y.;
Cuevas, B. D.;
Johnson, G. L.;
Futscher, B. W.;
Blancafort, P.

Publication type:

Article

Ribosomal protein S27L is a direct p53 target that regulates apoptosis.

Published in:

Oncogene, 2007, v. 26, n. 19, p. 2707, doi. 10.1038/sj.onc.1210073

By:

He, H.;
Sun, Y.

Publication type:

Article

XRCC4 in G1 suppresses homologous recombination in S/G2, in G1 checkpoint-defective cells.

Published in:

Oncogene, 2007, v. 26, n. 19, p. 2769, doi. 10.1038/sj.onc.1210075

By:

Saintigny, Y.;
Delacôte, F.;
Boucher, D.;
Averbeck, D.;
Lopez, B. S.

Publication type:

Article

Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells.

Published in:

Oncogene, 2007, v. 26, n. 19, p. 2759, doi. 10.1038/sj.onc.1210076

By:

Sebens Müerköster, S.;
Werbing, V.;
Sipos, B.;
Debus, M. A.;
Witt, M.;
Großmann, M.;
Leisner, D.;
Kötteritzsch, J.;
Kappes, H.;
Klöppel, G.;
Altevogt, P.;
Fölsch, U. R.;
Schäfer, H.

Publication type:

Article

CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases.

Published in:

Oncogene, 2007, v. 26, n. 19, p. 2747, doi. 10.1038/sj.onc.1210077

By:

Liu, W.;
Wei, W.;
Winer, D.;
Bamberger, A.-M.;
Bamberger, C.;
Wagener, C.;
Ezzat, S.;
Asa, S. L.

Publication type:

Article

Thymosin β4 triggers an epithelial–mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase.

Published in:

Oncogene, 2007, v. 26, n. 19, p. 2781, doi. 10.1038/sj.onc.1210078

By:

Huang, H.-C.;
Hu, C.-H.;
Tang, M.-C.;
Wang, W.-S.;
Chen, P.-M.;
Su, Y.

Publication type:

Article

Cross-talk between calpain and caspase-3/-7 in cisplatin-induced apoptosis of melanoma cells: a major role of calpain inhibition in cell death protection and p53 status.

Published in:

Oncogene, 2007, v. 26, n. 19, p. 2717, doi. 10.1038/sj.onc.1210079

By:

Del Bello, B.;
Moretti, D.;
Gamberucci, A.;
Maellaro, E.

Publication type:

Article

Suppression of hypoxic cell death by APIP-induced sustained activation of AKT and ERK1/2.

Published in:

Oncogene, 2007, v. 26, n. 19, p. 2809, doi. 10.1038/sj.onc.1210080

By:

Cho, D.-H.;
Lee, H.-J.;
Kim, H.-J.;
Hong, S.-H.;
Pyo, J.-O.;
Cho, C.;
Jung, Y.-K.

Publication type:

Article

The EVI5 TBC domain provides the GTPase-activating protein motif for RAB11.

Published in:

Oncogene, 2007, v. 26, n. 19, p. 2804, doi. 10.1038/sj.onc.1210081

By:

Dabbeekeh, J. T. S.;
Faitar, S. L.;
Dufresne, C. P.;
Cowell, J. K.

Publication type:

Article

miR-21-mediated tumor growth.

Published in:

Oncogene, 2007, v. 26, n. 19, p. 2799, doi. 10.1038/sj.onc.1210083

By:

Si, M.-L.;
Zhu, S.;
Wu, H.;
Lu, Z.;
Wu, F.;
Mo, Y.-Y.

Publication type:

Article

Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells.

Published in:

Oncogene, 2007, v. 26, n. 19, p. 2736, doi. 10.1038/sj.onc.1210084

By:

Basaki, Y.;
Hosoi, F.;
Oda, Y.;
Fotovati, A.;
Maruyama, Y.;
Oie, S.;
Ono, M.;
Izumi, H.;
Kohno, K.;
Sakai, K.;
Shimoyama, T.;
Nishio, K.;
Kuwano, M.

Publication type:

Article

Targeting an E2F site in the mouse genome prevents promoter silencing in quiescent and post-mitotic cells.

Published in:

Oncogene, 2007, v. 26, n. 19, p. 2727, doi. 10.1038/sj.onc.1210087

By:

Tavner, F.;
Frampton, J.;
Watson, R. J.

Publication type:

Article

Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.

Published in:

Oncogene, 2007, v. 26, n. 19, p. 2685, doi. 10.1038/sj.onc.1210089

By:

Starczynowski, D. T.;
Trautmann, H.;
Pott, C.;
Harder, L.;
Arnold, N.;
Africa, J. A.;
Leeman, J. R.;
Siebert, R.;
Gilmore, T. D.

Publication type:

Article

Regulation of survivin expression by IGF-1/mTOR signaling.

Published in:

Oncogene, 2007, v. 26, n. 19, p. 2678, doi. 10.1038/sj.onc.1210094

By:

Vaira, V.;
Lee, C. W.;
Goel, H. L.;
Bosari, S.;
Languino, L. R.;
Altieri, D. C.

Publication type:

Article

Highlights of the 23rd Genes and Cancer meeting University of Warwick 11–13 December 2006.

Published in:

2007

By:

Labib, K.

Publication type:

Conference Paper/Materials